ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,742 | 996 | 3,359 | 301 | -3,132 |
| Depreciation Amortization | 2,596 | 1,409 | 703 | 1,110 | 673 |
| Accounts receivable | -2,057 | 4,719 | 1,606 | -7,081 | -4,083 |
| Other Working Capital | -1,765 | 2,702 | 1,070 | -11,371 | -4,559 |
| Other Operating Activity | 4,776 | -2,693 | -1,559 | 11,557 | 8,482 |
| Operating Cash Flow | $11,292 | $7,133 | $5,179 | $-5,484 | $-2,619 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -782 | -371 | -118 | -191 | -162 |
| Purchase Sale Intangibles | -34,634 | -12,517 | -12,517 | N/A | N/A |
| Other Investing Activity | -34,634 | -12,517 | -12,517 | 20,458 | 18,198 |
| Investing Cash Flow | $-35,416 | $-12,888 | $-12,635 | $20,267 | $18,036 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 47,637 | 47,603 | 47,617 | 809 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -433 | -433 |
| Other Financing Activity | 432 | 8 | 107 | -4,065 | -4,065 |
| Financing Cash Flow | $48,069 | $47,611 | $47,724 | $-3,689 | $-4,498 |
| Beginning Cash Position | 11,105 | 11,105 | 11,105 | 11 | 11 |
| End Cash Position | 35,050 | 52,961 | 51,373 | 11,105 | 10,930 |
| Net Cash Flow | $23,945 | $41,856 | $40,268 | $11,094 | $10,919 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,292 | 7,133 | 5,179 | -5,484 | -2,619 |
| Capital Expenditure | -782 | -371 | -118 | -191 | -162 |
| Free Cash Flow | 10,510 | 6,762 | 5,061 | -5,675 | -2,781 |